Felder Predicts Clinical Laboratory Automation to Become Faster, More Efficient
Laboratory automation technology is ready and about to move into production
Most large clinical pathology laboratories in the United States and other developed nations now have a decade or more of experience with laboratory automation. In response to what is now a substantial market for laboratory automation, in vitro diagnostics (IVD) manufacturers are preparing to introduce the next generation of laboratory automation.
“Lab automation is a market, particularly in Asia, that has reached what we call mid-level maturity. It is no longer unusual to have an automated laboratory, it’s almost routine. Today, the question is ‘what’s next?’” observed Robin A. Felder, Ph.D. , publisher of Medical Automation and Professor of Pathology and Associate Director of Clinical Chemistry at the University of Virginia in Charlottesville, Virginia.
